Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
HDL Therapeutics Logo
HDL Therapeutics Growth Score
51
CB Rank
117879
Heat Score
50
HDL Therapeutics is a medical device company that develops cardiovascular therapeutic device designed to fight heart disease.
Founded
obfuscation
PrivateSeries E Vero Beach, Florida, United States1-10 hdltherapeutics.com
Biotechnology
Health Care
Medical Device
Therapeutics
Overview

HDL Therapeutics
Total Funding
obfuscation
Growth Score
51
Heat Score
50

Total Funding
obfuscation
obfuscation
Series E raised
obfuscation
Growth Score51
-6 pts
in past quarter
Heat Score 50
-18 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About HDL Therapeutics

CB Rank
117879
HDL Therapeutics is a medical device company that develops cardiovascular therapeutic device designed to fight heart disease.
Founded
obfuscation
PrivateSeries E Vero Beach, Florida, United States1-10 hdltherapeutics.com
Biotechnology
Health Care
Medical Device
Therapeutics

Funding Rounds

Series E
OBF
in
obfuscation
Series D
OBF
in
obfuscation
Series C
OBF
in
obfuscation

Key People

Details

Legal Name HDL Therapeutics, Inc.
Operating Status Active
Company Type For Profit
Founders  Bryan Brewer, Michael Matin
About the Company
HDL Therapeutics have developed the first therapy of its kind to rapidly reverse coronary atherosclerosis in patients with Homozygous Familial Hypercholesterolemia (HoFH).
Phone Number (772) 453-2770
Contact Email info@hdltherapeutics.com
Predictions & Insights

Growth Insight

See this Growth Insight
HDL Therapeutics is
Lorem
 to be growing
Top Contributing Factors
Merger or Acquisition

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Growth Insight

Products & Services

PDS-2™ System
An FDA-approved cardiovascular therapeutic device designed to increase HDL levels and reduce coronary artery plaques in patients with homozygous familial hypercholesterolemia (HoFH).

Research & Development

HDL Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series E - HDL Therapeutics Logo
Series E - HDL Therapeutics
—
obfuscation
— Series E
obfuscation
Series E - HDL Therapeutics Logo
Series E - HDL Therapeutics
—
obfuscation
— Series E
obfuscation
Series E - HDL Therapeutics Logo
Series E - HDL Therapeutics
—
obfuscation
— Series E
obfuscation
Series E - HDL Therapeutics Logo
Series E - HDL Therapeutics
—
obfuscation
— Series E
obfuscation
Series E - HDL Therapeutics Logo
Series E - HDL Therapeutics
—
obfuscation
— Series E

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series E - HDL Therapeutics Logo
Series E - HDL Therapeutics
—
obfuscation
— Series E
obfuscation
Series E - HDL Therapeutics Logo
Series E - HDL Therapeutics
—
obfuscation
— Series E
obfuscation
Series E - HDL Therapeutics Logo
Series E - HDL Therapeutics
—
obfuscation
— Series E
obfuscation
Series E - HDL Therapeutics Logo
Series E - HDL Therapeutics
—
obfuscation
— Series E
obfuscation
Series E - HDL Therapeutics Logo
Series E - HDL Therapeutics
—
obfuscation
— Series E

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 2 Board Members and Advisors 1

Employee Profiles

Board Members and Advisors

News

News and Press

News•Jan 12, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Sep 12, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Aug 11, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Oct 12, 2022
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

307
106.04%
 in past month

IT Spend

$152.6KThis year, HDL Therapeutics is projected to spend $152.6K on IT, according to Aberdeen.

Actively Used Products

10HDL Therapeutics uses 10 technology products and services including HTML5, Google Fonts, and  Google Maps API, according to G2 Stack.

Active Website Tech Count

4HDL Therapeutics is actively using 4 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m, U.S. Server Location, and  WordPress 6.9.

Total IP

14The intellectual property of HDL Therapeutics includes 14 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is HDL Therapeutics's headquarters? HDL Therapeutics is located in Vero Beach, Florida, United States.When was the last funding round for HDL Therapeutics? HDL Therapeutics closed its last funding round on
obfuscation
from a Series E round.Who are HDL Therapeutics's competitors? Alternatives and possible competitors to HDL Therapeutics may include Verve Therapeutics, Merck, and  Fresenius Medical Care.How much funding has HDL Therapeutics raised to date? HDL Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(397c9a6 1)
|